133 related articles for article (PubMed ID: 28566285)
1. Comparison of
James AD; Marvalin C; Luneau A; Meissner A; Camenisch G
Drug Metab Dispos; 2017 Aug; 45(8):900-907. PubMed ID: 28566285
[TBL] [Abstract][Full Text] [Related]
2. Comparison between Radioanalysis and
Hu H; Katyayan KK; Czeskis BA; Perkins EJ; Kulanthaivel P
Drug Metab Dispos; 2017 Apr; 45(4):399-408. PubMed ID: 28188298
[TBL] [Abstract][Full Text] [Related]
3. Alternate strategies to obtain mass balance without the use of radiolabeled compounds: application of quantitative fluorine (19F) nuclear magnetic resonance (NMR) spectroscopy in metabolism studies.
Mutlib A; Espina R; Atherton J; Wang J; Talaat R; Scatina J; Chandrasekaran A
Chem Res Toxicol; 2012 Mar; 25(3):572-83. PubMed ID: 22292524
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution, metabolism, and excretion of [(14)C]BYL719 (alpelisib) in healthy male volunteers.
James A; Blumenstein L; Glaenzel U; Jin Y; Demailly A; Jakab A; Hansen R; Hazell K; Mehta A; Trandafir L; Swart P
Cancer Chemother Pharmacol; 2015 Oct; 76(4):751-60. PubMed ID: 26254025
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development.
Singh RSP; Walker GS; Kadar EP; Cox LM; Eng H; Sharma R; Bergman AJ; Van Eyck L; Hackman F; Toussi SS; Kalgutkar AS; Obach RS
Clin Pharmacol Ther; 2022 Dec; 112(6):1201-1206. PubMed ID: 35678736
[TBL] [Abstract][Full Text] [Related]
6.
Pearson D; Garnier M; Luneau A; James AD; Walles M
Xenobiotica; 2019 Aug; 49(8):953-960. PubMed ID: 30215545
[TBL] [Abstract][Full Text] [Related]
7. Detection, identification and quantification of a new de-fluorinated impurity in casopitant mesylate drug substance during late phase development: an analytical challenge involving a multidisciplinary approach.
Turco L; Provera S; Curcuruto O; Bernabè E; Nicoletti A; Martini L; Castoldi D; Cimarosti Z; Papini D; Marchioro C; Dams R
J Pharm Biomed Anal; 2011 Jan; 54(1):67-73. PubMed ID: 20813481
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of human ADME and mass balance studies using regular or low doses of radiocarbon.
Roffel AF; van Marle SP; van Lier JJ; Hartstra J; van Hoogdalem EJ
J Labelled Comp Radiopharm; 2016 Dec; 59(14):619-626. PubMed ID: 28000265
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 3-chloro-4-fluoroaniline in rat using [14C]-radiolabelling, 19F-NMR spectroscopy, HPLC-MS/MS, HPLC-ICPMS and HPLC-NMR.
Duckett CJ; Lindon JC; Walker H; Abou-Shakra F; Wilson ID; Nicholson JK
Xenobiotica; 2006 Jan; 36(1):59-77. PubMed ID: 16507513
[TBL] [Abstract][Full Text] [Related]
10. Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches.
Beaumont C; Young GC; Cavalier T; Young MA
Br J Clin Pharmacol; 2014 Dec; 78(6):1185-200. PubMed ID: 25041729
[TBL] [Abstract][Full Text] [Related]
11. The application of
Liu CM; Song CH; Jia W; Hua ZD; Liao Q
Forensic Sci Int; 2022 Nov; 340():111450. PubMed ID: 36152449
[TBL] [Abstract][Full Text] [Related]
12. Identifying Unknown Fluorine-Containing Compounds in Environmental Samples Using
Gauthier JR; Mabury SA
Environ Sci Technol; 2023 Jun; 57(23):8760-8767. PubMed ID: 37259970
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance.
Frison G; Odoardi S; Frasson S; Sciarrone R; Ortar G; Romolo FS; Strano Rossi S
Rapid Commun Mass Spectrom; 2015 Jul; 29(13):1196-204. PubMed ID: 26395784
[TBL] [Abstract][Full Text] [Related]
14. Mini-Review: Comprehensive Drug Disposition Knowledge Generated in the Modern Human Radiolabeled ADME Study.
Spracklin DK; Chen D; Bergman AJ; Callegari E; Obach RS
CPT Pharmacometrics Syst Pharmacol; 2020 Aug; 9(8):428-434. PubMed ID: 32562380
[TBL] [Abstract][Full Text] [Related]
15. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
16. Isolation and identification of human metabolites from a novel anti-tumor candidate drug 5-chlorogenic acid injection by HPLC-HRMS/MS
Ren T; Wang Y; Wang C; Zhang M; Huang W; Jiang J; Li W; Zhang J
Anal Bioanal Chem; 2017 Dec; 409(30):7035-7048. PubMed ID: 29116355
[TBL] [Abstract][Full Text] [Related]
17. High resolution ¹⁹F{¹H} nuclear magnetic resonance spectroscopy and liquid chromatography-solid phase extraction-offline ¹H nuclear magnetic resonance spectroscopy for conclusive detection and identification of cyanide in water samples.
Mazumder A; Kumar A; Dubey DK
J Chromatogr A; 2013 Apr; 1284():88-99. PubMed ID: 23453678
[TBL] [Abstract][Full Text] [Related]
18. Biodegradation pathway of mesotrione: complementarities of NMR, LC-NMR and LC-MS for qualitative and quantitative metabolic profiling.
Durand S; Sancelme M; Besse-Hoggan P; Combourieu B
Chemosphere; 2010 Sep; 81(3):372-80. PubMed ID: 20692682
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometry.
Liu DQ; Karanam BV; Doss GA; Sidler RR; Vincent SH; Hop CE
Drug Metab Dispos; 2004 Sep; 32(9):1023-31. PubMed ID: 15319345
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
